PCSA
NASDAQ · Pharmaceuticals
Processa Pharmaceuticals Inc
$2.41
+0.08 (+3.43%)
Open$2.37
Previous Close$2.33
Day High$2.45
Day Low$2.32
52W High$19.63
52W Low$1.76
Volume—
Avg Volume40.8K
Market Cap6.20M
P/E Ratio—
EPS$-16.34
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,431.1% upside
Current
$2.41
$2.41
Target
$36.90
$36.90
$23.79
$36.90 avg
$41.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.71M | 2.46M | 2.10M |
| Net Income | 319.8K | 302.9K | 327.4K |
| Profit Margin | 11.8% | 12.3% | 15.6% |
| EBITDA | 521.3K | 563.7K | 431.6K |
| Free Cash Flow | 364.0K | 435.1K | 285.7K |
| Rev Growth | +2.4% | +0.4% | +18.3% |
| Debt/Equity | 0.28 | 0.35 | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |